Home Keryx Biopharmaceuticals Announces Results From Ferric Citrate Phase...
 

Keywords :   


Keryx Biopharmaceuticals Announces Results From Ferric Citrate Phase...

2014-11-15 20:32:22| Biotech - Topix.net

Keryx Biopharmaceuticals, Inc. today announced results from a 48-week Open Label Extension safety study in which Ferric Citrate demonstrated long-term safety and efficacy in dialysis-dependent chronic kidney disease patients with elevated serum phosphorus levels, or hyperphosphatemia. The OLE findings were presented as a late-breaking poster at the 2014 American Society of Nephrology's Kidney Week meeting in Philadelphia, PA.

Tags: results phase announces citrate

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 7
05.11Tropical Storm Rafael Public Advisory Number 7
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 7
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
More »